A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal west nile virus infection in aged mice

Amelia K. Pinto, Justin M. Richner, Elizabeth A. Poore, Pradnya P. Patil, Ian J. Amanna, Mark Slifka, Michael S. Diamond

    Research output: Contribution to journalArticle

    38 Citations (Scopus)

    Abstract

    West Nile virus (WNV) is an emerging pathogen that is now the leading cause of mosquito-borne and epidemic encephalitis in the United States. In humans, a small percentage of infected individuals develop severe neuroinvasive disease, with the greatest relative risk being in the elderly and immunocompromised, two populations that are difficult to immunize effectively with vaccines. While inactivated and subunit-based veterinary vaccines against WNV exist, currently there is no vaccine or therapy available to prevent or treat human disease. Here, we describe the generation and preclinical efficacy of a hydrogen peroxide (H2O2)- inactivated WNV Kunjin strain (WNV-KUNV) vaccine as a candidate for further development. Both young and aged mice vaccinated with H2O2-inactivated WNV-KUNV produced robust adaptive B and T cell immune responses and were protected against stringent and lethal intracranial challenge with a heterologous virulent North American WNV strain. Our studies suggest that the H2O2-inactivated WNV-KUNV vaccine is safe and immunogenic and may be suitable for protection against WNV infection in vulnerable populations.

    Original languageEnglish (US)
    Pages (from-to)1926-1936
    Number of pages11
    JournalJournal of Virology
    Volume87
    Issue number4
    DOIs
    StatePublished - Feb 2013

    Fingerprint

    West Nile virus
    Inactivated Vaccines
    West Nile Virus Vaccines
    Virus Diseases
    Humoral Immunity
    humoral immunity
    Cellular Immunity
    cell-mediated immunity
    Hydrogen Peroxide
    hydrogen peroxide
    vaccines
    Viruses
    Arbovirus Encephalitis
    viruses
    mice
    infection
    Active Immunotherapy
    Vulnerable Populations
    B-Lymphocytes
    Vaccines

    ASJC Scopus subject areas

    • Immunology
    • Virology

    Cite this

    A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal west nile virus infection in aged mice. / Pinto, Amelia K.; Richner, Justin M.; Poore, Elizabeth A.; Patil, Pradnya P.; Amanna, Ian J.; Slifka, Mark; Diamond, Michael S.

    In: Journal of Virology, Vol. 87, No. 4, 02.2013, p. 1926-1936.

    Research output: Contribution to journalArticle

    Pinto, Amelia K. ; Richner, Justin M. ; Poore, Elizabeth A. ; Patil, Pradnya P. ; Amanna, Ian J. ; Slifka, Mark ; Diamond, Michael S. / A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal west nile virus infection in aged mice. In: Journal of Virology. 2013 ; Vol. 87, No. 4. pp. 1926-1936.
    @article{8ea711938abf4849bf03cf14c98e039b,
    title = "A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal west nile virus infection in aged mice",
    abstract = "West Nile virus (WNV) is an emerging pathogen that is now the leading cause of mosquito-borne and epidemic encephalitis in the United States. In humans, a small percentage of infected individuals develop severe neuroinvasive disease, with the greatest relative risk being in the elderly and immunocompromised, two populations that are difficult to immunize effectively with vaccines. While inactivated and subunit-based veterinary vaccines against WNV exist, currently there is no vaccine or therapy available to prevent or treat human disease. Here, we describe the generation and preclinical efficacy of a hydrogen peroxide (H2O2)- inactivated WNV Kunjin strain (WNV-KUNV) vaccine as a candidate for further development. Both young and aged mice vaccinated with H2O2-inactivated WNV-KUNV produced robust adaptive B and T cell immune responses and were protected against stringent and lethal intracranial challenge with a heterologous virulent North American WNV strain. Our studies suggest that the H2O2-inactivated WNV-KUNV vaccine is safe and immunogenic and may be suitable for protection against WNV infection in vulnerable populations.",
    author = "Pinto, {Amelia K.} and Richner, {Justin M.} and Poore, {Elizabeth A.} and Patil, {Pradnya P.} and Amanna, {Ian J.} and Mark Slifka and Diamond, {Michael S.}",
    year = "2013",
    month = "2",
    doi = "10.1128/JVI.02903-12",
    language = "English (US)",
    volume = "87",
    pages = "1926--1936",
    journal = "Journal of Virology",
    issn = "0022-538X",
    publisher = "American Society for Microbiology",
    number = "4",

    }

    TY - JOUR

    T1 - A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal west nile virus infection in aged mice

    AU - Pinto, Amelia K.

    AU - Richner, Justin M.

    AU - Poore, Elizabeth A.

    AU - Patil, Pradnya P.

    AU - Amanna, Ian J.

    AU - Slifka, Mark

    AU - Diamond, Michael S.

    PY - 2013/2

    Y1 - 2013/2

    N2 - West Nile virus (WNV) is an emerging pathogen that is now the leading cause of mosquito-borne and epidemic encephalitis in the United States. In humans, a small percentage of infected individuals develop severe neuroinvasive disease, with the greatest relative risk being in the elderly and immunocompromised, two populations that are difficult to immunize effectively with vaccines. While inactivated and subunit-based veterinary vaccines against WNV exist, currently there is no vaccine or therapy available to prevent or treat human disease. Here, we describe the generation and preclinical efficacy of a hydrogen peroxide (H2O2)- inactivated WNV Kunjin strain (WNV-KUNV) vaccine as a candidate for further development. Both young and aged mice vaccinated with H2O2-inactivated WNV-KUNV produced robust adaptive B and T cell immune responses and were protected against stringent and lethal intracranial challenge with a heterologous virulent North American WNV strain. Our studies suggest that the H2O2-inactivated WNV-KUNV vaccine is safe and immunogenic and may be suitable for protection against WNV infection in vulnerable populations.

    AB - West Nile virus (WNV) is an emerging pathogen that is now the leading cause of mosquito-borne and epidemic encephalitis in the United States. In humans, a small percentage of infected individuals develop severe neuroinvasive disease, with the greatest relative risk being in the elderly and immunocompromised, two populations that are difficult to immunize effectively with vaccines. While inactivated and subunit-based veterinary vaccines against WNV exist, currently there is no vaccine or therapy available to prevent or treat human disease. Here, we describe the generation and preclinical efficacy of a hydrogen peroxide (H2O2)- inactivated WNV Kunjin strain (WNV-KUNV) vaccine as a candidate for further development. Both young and aged mice vaccinated with H2O2-inactivated WNV-KUNV produced robust adaptive B and T cell immune responses and were protected against stringent and lethal intracranial challenge with a heterologous virulent North American WNV strain. Our studies suggest that the H2O2-inactivated WNV-KUNV vaccine is safe and immunogenic and may be suitable for protection against WNV infection in vulnerable populations.

    UR - http://www.scopus.com/inward/record.url?scp=84873805878&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84873805878&partnerID=8YFLogxK

    U2 - 10.1128/JVI.02903-12

    DO - 10.1128/JVI.02903-12

    M3 - Article

    C2 - 23221549

    AN - SCOPUS:84873805878

    VL - 87

    SP - 1926

    EP - 1936

    JO - Journal of Virology

    JF - Journal of Virology

    SN - 0022-538X

    IS - 4

    ER -